Detalhe da pesquisa
1.
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Gastroenterology
; 157(1): 227-241.e7, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930022
2.
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Gastroenterology
; 154(6): 1764-1777.e7, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378197
3.
HBV pre-core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood.
J Med Virol
; 90(7): 1232-1239, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29488227
4.
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Liver Int
; 37(11): 1622-1631, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296013
5.
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.
J Hepatol
; 62(2): 486-91, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25308176
6.
Highly dynamic changes of regional HBV epidemiology over two decades.
Dig Liver Dis
; 55(4): 519-526, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404234
7.
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection.
Viruses
; 15(11)2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38005933
8.
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy.
J Clin Med
; 11(5)2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35268497
9.
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
Gastroenterology
; 139(2): 483-90, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20451520
10.
Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib.
Cancers (Basel)
; 13(9)2021 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922938
11.
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis.
Aliment Pharmacol Ther
; 53(6): 733-744, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465257
12.
Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
Aliment Pharmacol Ther
; 51(12): 1406-1416, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390175
13.
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma.
Cancer Biomark
; 29(2): 189-196, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32623383
14.
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Cancer Biomark
; 21(3): 603-612, 2018 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278878
15.
Genome-Wide Comparison of Next-Generation Sequencing and qPCR Platforms for microRNA Profiling in Serum.
Methods Mol Biol
; 1580: 21-44, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439824
16.
Editorial: which factors influence HBsAg levels in HBV-infected patients? Authors' reply.
Aliment Pharmacol Ther
; 52(3): 549-550, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656824
17.
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
PLoS One
; 10(6): e0130209, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115521
18.
Tamm-Horsfall glycoprotein: biology and clinical relevance.
Am J Kidney Dis
; 42(4): 658-76, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14520616
19.
Salt-precipitation method does not isolate to homogeneity Tamm-Horsfall glycoprotein from urine of proteinuric patients and pregnant women.
Clin Biochem
; 35(5): 405-10, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12270772
20.
A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
PLoS One
; 9(10): e110782, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25350115